Dr. Robinson will serve as a co-investigator (PI at the Northwestern University) and provide guidance on design issues, measurement, qualitative research including framing presentation of the risk of developing melanoma and benefits of performing skin self-examination (SSE) with melanoma patients and their first-degree relatives. In the first six months, Dr. Robinson and her staff will validate her existing SSE measures with first-degree relatives in a test, re-test process with 60 individuals. She will also conduct a randomized-controlled trial with melanoma patients and their first-degree relatives to evaluate the effectiveness of the program to enhance early detection of melanoma in this at-risk group. The RCT with 400 melanoma patients and 400 of their first-degree relatives will include four self-reported measurements of knowledge, attitudes, and performance of SSE. Subjects will have images of moles evaluated by Dr. June Robinson. Subject reimbursement will be provided by Eviderma staff.
|Effective start/end date||1/20/17 → 1/19/19|
- Vignet Inc. (HHSN261201700003C)
- National Cancer Institute (HHSN261201700003C)